Cyclerion Therapeutics (CYCN) Other Operating Expenses (2019 - 2025)
Cyclerion Therapeutics (CYCN) posted quarterly Other Operating Expenses of $1.3 million for Q2 2025, down 60.65% quarter-over-quarter from $3.3 million in Q3 2023.
Cyclerion Therapeutics (CYCN) Other Operating Expenses (2019 - 2025) Analysis & Trends
Cyclerion Therapeutics' Other Operating Expenses history runs 5 years deep, the most recent figure standing at $1.3 million for Q2 2025.
- In Q2 2025, Other Operating Expenses changed N/A year-over-year to $1.3 million; the TTM figure through Dec 2025 stood at $1.3 million (changed N/A YoY), while the FY2023 annual figure was $3.3 million, changed N/A from the prior year.
- Other Operating Expenses for Q2 2025 stood at $1.3 million, down from $3.3 million in the prior quarter.
- The five-year high for Other Operating Expenses was $3.3 million in Q3 2023, with the low at $881000.0 in Q2 2021.
- The 3-year median for Other Operating Expenses is $1.3 million (2025), against an average of $1.8 million.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Cyclerion Therapeutics | 12.71 Mn | 9.47 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 1.30 Mn |
| Sep 30, 2023 | 3.30 Mn |
| Jun 30, 2021 | 881,000.00 |
| Sep 30, 2020 | 444,000.00 |
| Mar 31, 2020 | -2.11 Mn |
| Dec 31, 2019 | -27.87 Mn |